144 related articles for article (PubMed ID: 1725722)
1. Angiogenesis and its inhibition: potential new therapies in oncology and non-neoplastic diseases.
Billington DC
Drug Des Discov; 1991 Nov; 8(1):3-35. PubMed ID: 1725722
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
4. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis: an update.
Díaz-Flores L; Gutiérrez R; Varela H
Histol Histopathol; 1994 Oct; 9(4):807-43. PubMed ID: 7534514
[TBL] [Abstract][Full Text] [Related]
6. [Angiogenesis and its regulation].
Iwaguchi T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):1-9. PubMed ID: 7678486
[TBL] [Abstract][Full Text] [Related]
7. [Neoplasms and angiogenesis].
Lewy-Trenda I
Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
9. Are tumours angiogenesis-dependent?
Verheul HM; Voest EE; Schlingemann RO
J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
[TBL] [Abstract][Full Text] [Related]
10. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and its inhibitors.
Folkman J
Important Adv Oncol; 1985; ():42-62. PubMed ID: 2453453
[TBL] [Abstract][Full Text] [Related]
12. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of tumor angiogenesis as a cancer treatment].
Verheul HM; Bom JB; Hoekman K; Pinedo HM
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis.
Folkman J; Ingber D
Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic function of tocotrienol.
Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
[TBL] [Abstract][Full Text] [Related]
18. Multifocal angiostatic therapy: an update.
McCarty MF; Block KI
Integr Cancer Ther; 2005 Dec; 4(4):301-14. PubMed ID: 16282507
[TBL] [Abstract][Full Text] [Related]
19. [Tumor angiogenesis].
Bussolino F
Recenti Prog Med; 1999 Jan; 90(1):28-36. PubMed ID: 10193163
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
Veale DJ; Fearon U
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):941-7. PubMed ID: 16980216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]